174 related articles for article (PubMed ID: 32730653)
1. Demyelination in hereditary sensory neuropathy type-1C.
Saba S; Chen Y; Maddipati KR; Hackett M; Hu B; Li J
Ann Clin Transl Neurol; 2020 Sep; 7(9):1502-1512. PubMed ID: 32730653
[TBL] [Abstract][Full Text] [Related]
2. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C.
Suriyanarayanan S; Othman A; Dräger B; Schirmacher A; Young P; Mulahasanovic L; Hörtnagel K; Biskup S; von Eckardstein A; Hornemann T; Lone MA
Neuromolecular Med; 2019 Jun; 21(2):182-191. PubMed ID: 30955194
[TBL] [Abstract][Full Text] [Related]
3. Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.
Murphy SM; Ernst D; Wei Y; Laurà M; Liu YT; Polke J; Blake J; Winer J; Houlden H; Hornemann T; Reilly MM
Neurology; 2013 Jun; 80(23):2106-11. PubMed ID: 23658386
[TBL] [Abstract][Full Text] [Related]
4. The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.
Suriyanarayanan S; Auranen M; Toppila J; Paetau A; Shcherbii M; Palin E; Wei Y; Lohioja T; Schlotter-Weigel B; Schön U; Abicht A; Rautenstrauss B; Tyynismaa H; Walter MC; Hornemann T; Ylikallio E
Neuromolecular Med; 2016 Mar; 18(1):81-90. PubMed ID: 26573920
[TBL] [Abstract][Full Text] [Related]
5. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
[TBL] [Abstract][Full Text] [Related]
6. Hereditary sensory and autonomic neuropathy type IC accompanied by upper motor neuron abnormalities and type II juxtafoveal retinal telangiectasias.
Triplett J; Nicholson G; Sue C; Hornemann T; Yiannikas C
J Peripher Nerv Syst; 2019 Jun; 24(2):224-229. PubMed ID: 30866134
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
[TBL] [Abstract][Full Text] [Related]
8. Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.
Ernst D; Murphy SM; Sathiyanadan K; Wei Y; Othman A; Laurá M; Liu YT; Penno A; Blake J; Donaghy M; Houlden H; Reilly MM; Hornemann T
Neuromolecular Med; 2015 Mar; 17(1):47-57. PubMed ID: 25567748
[TBL] [Abstract][Full Text] [Related]
9. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I.
Rotthier A; Auer-Grumbach M; Janssens K; Baets J; Penno A; Almeida-Souza L; Van Hoof K; Jacobs A; De Vriendt E; Schlotter-Weigel B; Löscher W; Vondráček P; Seeman P; De Jonghe P; Van Dijck P; Jordanova A; Hornemann T; Timmerman V
Am J Hum Genet; 2010 Oct; 87(4):513-22. PubMed ID: 20920666
[TBL] [Abstract][Full Text] [Related]
11. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
[TBL] [Abstract][Full Text] [Related]
12. Functional and Molecular Characterization of New
Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
[TBL] [Abstract][Full Text] [Related]
13. Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C.
Auranen M; Toppila J; Suriyanarayanan S; Lone MA; Paetau A; Tyynismaa H; Hornemann T; Ylikallio E
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29042446
[TBL] [Abstract][Full Text] [Related]
14. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy.
Dawkins JL; Brahmbhatt S; Auer-Grumbach M; Wagner K; Hartung HP; Verhoeven K; Timmerman V; De Jonghe P; Kennerson M; LeGuern E; Nicholson GA
Neuromuscul Disord; 2002 Oct; 12(7-8):656-8. PubMed ID: 12207934
[TBL] [Abstract][Full Text] [Related]
15. Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro.
Wilson ER; Kugathasan U; Abramov AY; Clark AJ; Bennett DLH; Reilly MM; Greensmith L; Kalmar B
Neurobiol Dis; 2018 Sep; 117():1-14. PubMed ID: 29778900
[TBL] [Abstract][Full Text] [Related]
16. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I).
Houlden H; King R; Blake J; Groves M; Love S; Woodward C; Hammans S; Nicoll J; Lennox G; O'Donovan DG; Gabriel C; Thomas PK; Reilly MM
Brain; 2006 Feb; 129(Pt 2):411-25. PubMed ID: 16364956
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
[TBL] [Abstract][Full Text] [Related]
18. Recurrent de novo
Syeda SB; Lone MA; Mohassel P; Donkervoort S; Munot P; França MC; Galarza-Brito JE; Eckenweiler M; Asamoah A; Gable K; Majumdar A; Schumann A; Gupta SD; Lakhotia A; Shieh PB; Foley AR; Jackson KE; Chao KR; Winder TL; Catapano F; Feng L; Kirschner J; Muntoni F; Dunn TM; Hornemann T; Bönnemann CG
J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):103-113. PubMed ID: 38041679
[TBL] [Abstract][Full Text] [Related]
19. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
[TBL] [Abstract][Full Text] [Related]
20. The N355K atlastin 1 mutation is associated with hereditary sensory neuropathy and pyramidal tract features.
Leonardis L; Auer-Grumbach M; Papić L; Zidar J
Eur J Neurol; 2012 Jul; 19(7):992-8. PubMed ID: 22340599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
